# Pay Less for Wegovy — If Your Body Lets You Stay - Date: 2026-03-31 - Category: Biotech & Life Sciences Novo Nordisk’s new Wegovy subscription saves patients up to $1,200 a year. The harder problem: roughly 65% of obesity patients quit GLP-1 drugs within 12 months. ---